1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

Electronic Prescribing Information: Proposed Rule May Not Completely Eliminate Paper

 
• By Brenda Sandburg

FDA expresses concerns about providing both paper and electronic versions of prescribing information to health care providers but seeks comments on dual systems anyway.

FDA’s long-awaited proposed rule requiring prescribing information distributed to health care professionals be in an electronic format aims to eliminate the use of paper. But the agency is requesting comments on whether a dual system providing both electronic and paper versions of prescribing information could provide the most current data.

The proposed rule, scheduled for publication in the Dec. 18 Federal Register, would not apply to patient labeling,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America

How Could MFN Pricing Impact Commercial Market?

 
• By Angela Maas

Industry experts forecast the impact of President Trump's Most-Favored Nation drug pricing policy on the commercial insurance industry.

COVID-19 mRNA Vaccine Labels Now Quantify Myocarditis Risk, But ACIP Wants Other Changes

 
• By Sue Sutter

New members of the CDC’s Advisory Committee on Immunization Practices suggested concerns beyond myocarditis, questioning whether test-negative observational studies are giving an incorrect picture of effectiveness.

Medicare’s Combo Products Negotiation Plan Conflicts With US FDA Standards, Firms Argue

 
• By Cathy Kelly

The plan could curtail a period of pricing flexibility for newer subcutaneous versions of important oncology drugs.